| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/25/1998 | CN1037842C Thiazole or imidazole derivatives as maillard reaction inhibitors |
| 03/25/1998 | CN1037841C Process for preparing substituted 4 -phenyl -4 - piperidinecarboxamide having local anaesthetis and analgestic effect |
| 03/25/1998 | CN1037840C Diphenylmethyl piperazine derivatives |
| 03/25/1998 | CN1037815C Use of the substituted azaspirane in the mfg. of a medieament for the treatment of psoriasis |
| 03/24/1998 | USRE35754 Cephem derivatives |
| 03/24/1998 | US5731455 Alkyl 2-alkylacylacrylate chemical intermediate; anticholesterol agents |
| 03/24/1998 | US5731454 Allosteric modifiers of hemoglobin useful for decreasing oxygen affinity and preserving oxygen carrying capability of stored blood |
| 03/24/1998 | US5731447 Process for preparing 16α-methyl-steroids |
| 03/24/1998 | US5731441 Hydroxamic acid derivatives with tricyclic substitution |
| 03/24/1998 | US5731438 Bactericides; drugs |
| 03/24/1998 | US5731436 Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents |
| 03/24/1998 | US5731432 Inhibitors of adenosine monophosphate deaminase |
| 03/24/1998 | US5731413 Liquid or solid phase biosynthesis |
| 03/24/1998 | US5731391 Fluid composition for physiological separations with enhanced resistance to inward migration of substances requiring accurate dosage monitoring |
| 03/24/1998 | US5731357 Immunomodulating active substance |
| 03/24/1998 | US5731356 Limiting growth of staphylococcus, candida, escherichia, and/or pseudomonas in anesthetic oil in water emulsion |
| 03/24/1998 | US5731355 Pharmaceutical compositions of propofol and edetate |
| 03/24/1998 | US5731354 Administering a metabolic precursor of phospholipids to a patient |
| 03/24/1998 | US5731352 Therapy for disorders of the melatoninergic system |
| 03/24/1998 | US5731351 Antiarrhythmia agents |
| 03/24/1998 | US5731350 Substituted benzenedicarboxylic acid diguanides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 03/24/1998 | US5731349 Glycine |
| 03/24/1998 | US5731348 Alkylcarboxy amino acids-modulators of the kainate receptor |
| 03/24/1998 | US5731347 Method of treating small mouth ulcers |
| 03/24/1998 | US5731346 Use of omega-3-fatty acids |
| 03/24/1998 | US5731345 Seco-D steroids active on the cardiovascular system and pharmaceutical compositions containing same |
| 03/24/1998 | US5731344 Diabetes, atherosclerosis, arteriosclerosis; inhibitors of advanced glycosylation endproducts |
| 03/24/1998 | US5731343 Method of use of radicicol for treatment of immunopathological disorders |
| 03/24/1998 | US5731340 Dietetics; antidiabetic agents |
| 03/24/1998 | US5731339 Administering vasodilator; phentolamine mesylate or hydrochloride |
| 03/24/1998 | US5731338 Controlled release pilocarpine delivery system |
| 03/24/1998 | US5731337 Conformationally rigid bicycle and adamantane derivatives useful as α2 |
| 03/24/1998 | US5731336 Method for treating multiple sclerosis |
| 03/24/1998 | US5731335 Nervous system disorders; stroke; antiischemic agents; cognition activators |
| 03/24/1998 | US5731333 Learning and memory enhancement, antidepressants |
| 03/24/1998 | US5731332 Leukotriene antagonists; antiinflammatory agents, antiallergens |
| 03/24/1998 | US5731331 Tetrahydropyridine-(or 4-hydroxypiperidine) alkylazoles |
| 03/24/1998 | US5731328 Administering 2-phenyl-3-aroylbenzothiophene compounds to a patient |
| 03/24/1998 | US5731327 Synthesis of 3- 4-(2-aminoethoxy)benzoyl!-2-aryl-6-hydroxybenzo b!thiophenes |
| 03/24/1998 | US5731326 Platelet derived growth factor |
| 03/24/1998 | US5731325 Treatment of melanomas with thalidomide alone or in combination with other anti-melanoma agents |
| 03/24/1998 | US5731324 Glycoprotein IIb/IIIa antagonists |
| 03/24/1998 | US5731323 Quinuclidine derivatives as squalene synthase inhibitors |
| 03/24/1998 | US5731322 Octahydro-1H-pyrrolo 3,2-g!and 2,3-g!isoquinoline derivatives |
| 03/24/1998 | US5731321 Endothelin receptor antagonists |
| 03/24/1998 | US5731319 Antiallergens; antihistamines |
| 03/24/1998 | US5731316 Derivatives of camptothecin and methods of treating cancer using these derivatives |
| 03/24/1998 | US5731315 Inhibitors of factor xa |
| 03/24/1998 | US5731314 Administering aryl substituted olefinic amine compounds or aryl substituted acetylenic amine compounds to a patient |
| 03/24/1998 | US5731313 Use of anthracyclinone derivatives in amyloidosis |
| 03/24/1998 | US5731312 Administering mixture of dopamine antagonist and prolactin inhibitor |
| 03/24/1998 | US5731311 N,N-di(aryl) cyclic urea derivatives as anti-coagulants |
| 03/24/1998 | US5731309 Asthma |
| 03/24/1998 | US5731308 N,N-di(aryl) cyclic urea derivatives as anti-coagulants |
| 03/24/1998 | US5731305 Anti-hypertension compositions of secondary amine-nitric oxide adducts and use thereof |
| 03/24/1998 | US5731304 Potentiation of temozolomide in human tumour cells |
| 03/24/1998 | US5731302 Colloidal cellulose, hydrophilic thickener |
| 03/24/1998 | US5731301 Bistriazenes as chemotherapeutic agents |
| 03/24/1998 | US5731299 Phosphonosulfonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism |
| 03/24/1998 | US5731298 Injecting crosslinked hyaluronic acid into scar |
| 03/24/1998 | US5731294 Inhibition of neovasularization using VEGF-specific oligonucleotides |
| 03/24/1998 | US5731293 Enzyme inhibitors |
| 03/24/1998 | US5731292 Dihydrochalcone derivatives which are hypoglycemic agents |
| 03/24/1998 | US5731290 Method of improving the immune response |
| 03/24/1998 | US5731287 Prolactin |
| 03/24/1998 | US5731284 Method for treating Alzheimer's disease using glial line-derived neurotrophic factor (GDNF) protein product |
| 03/24/1998 | US5731028 Crystallized zilpaterol hydrochloride |
| 03/24/1998 | US5731008 Electrically hydrolyzed salines as microbicides |
| 03/24/1998 | US5731007 Pharmaceutical composition for skin diseases |
| 03/24/1998 | US5731006 Gastrointestinal mucosa-adherent granules, pharmaceutical preparations and a coating composition |
| 03/24/1998 | US5731002 Antisecretory |
| 03/24/1998 | US5731000 Stabilized pharmaceutical composition containing bupropion |
| 03/24/1998 | US5730998 Administering substance p antagonist |
| 03/24/1998 | US5730992 Applying 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor to treat acne |
| 03/24/1998 | US5730990 Non-antigenic amine derived polymers and polymer conjugates |
| 03/24/1998 | US5730975 Treatment of insulin resistance in obesity linked type II diabetes using antagonist to TNF-alpha function |
| 03/24/1998 | US5730972 Mixture of saccharide ester of ascorbic acid and water soluble sulphonic compound |
| 03/24/1998 | US5730971 Mixture of flavin adenine dinucleotide and porcien liver extract |
| 03/24/1998 | US5730964 Method of treating sweat-related conditions |
| 03/24/1998 | US5730960 Sunscreen agent |
| 03/24/1998 | US5730759 Poly-substituted phthalocyanines |
| 03/24/1998 | US5730157 Glycerophosphoethanolamines |
| 03/24/1998 | CA2214919A1 Benzothiophene compounds, intermediates, processes, compositions, and methods |
| 03/24/1998 | CA2129037C Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers |
| 03/24/1998 | CA1339780C Antiviral phosphonomethoxyalkylene purine and pyrimidine derivatives |
| 03/24/1998 | CA1339770C Mitotic inhibitor and method for preventing posterior lens capsule opacification after extracapsular extraction |
| 03/23/1998 | CA2216222A1 1-carba-(dethia)-cephalosporin derivatives |
| 03/19/1998 | WO1998011435A1 Materials and methods relating to the diagnosis and treatment of diabetes and obesity |
| 03/19/1998 | WO1998011254A1 MUTATIONS IN THE DIABETES SUSCEPTIBILITY GENES HEPATOCYTE NUCLEAR FACTOR (HNF) 1 ALPHA (α), HNF-1β AND HNF-4$g(a) |
| 03/19/1998 | WO1998011236A1 Aspartic protease |
| 03/19/1998 | WO1998011229A2 Histidine-tagged shiga toxins, toxoids, and protein fusions with such toxins and toxoids, methods for the purification and preparation thereof |
| 03/19/1998 | WO1998011225A2 A novel haemopoietin receptor and genetic sequences encoding same |
| 03/19/1998 | WO1998011213A1 Method for treating amyotrophic lateral sclerosis |
| 03/19/1998 | WO1998011212A1 Ptx sensitive g proteins, the production and use thereof |
| 03/19/1998 | WO1998011211A2 METHOD FOR USING OLIGONUCLEOTIDES HAVING MODIFIED CpG DINUCLEOSIDES |
| 03/19/1998 | WO1998011141A1 Sulfated polysaccharides and uses thereof in medical treatment |
| 03/19/1998 | WO1998011128A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 03/19/1998 | WO1998011124A1 3-substituted-d-homo-1,3,5,(10)-estratriene derivatives |
| 03/19/1998 | WO1998011123A1 Carbamate-derivatized nucleosides and oligonucleosides |
| 03/19/1998 | WO1998011119A1 Novel pyranoside derivatives |